- Home
- POET vs CERS Comparison
POET vs CERS Comparison
Compare POET & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POET
- CERS
- Stock Information
- Founded
- POET 1972
- CERS 1991
- Country
- POET Canada
- CERS United States
- Employees
- POET N/A
- CERS N/A
- Industry
- POET Semiconductors
- CERS EDP Services
- Sector
- POET Technology
- CERS Technology
- Exchange
- POET Nasdaq
- CERS Nasdaq
- Market Cap
- POET 401.2M
- CERS 347.3M
- IPO Year
- POET N/A
- CERS 1997
- Fundamental
- Price
- POET $4.74
- CERS $1.86
- Analyst Decision
- POET Strong Buy
- CERS Buy
- Analyst Count
- POET 2
- CERS 3
- Target Price
- POET $6.25
- CERS $3.17
- AVG Volume (30 Days)
- POET 2.0M
- CERS 1.7M
- Earning Date
- POET 03-14-2025
- CERS 03-04-2025
- Dividend Yield
- POET N/A
- CERS N/A
- EPS Growth
- POET N/A
- CERS N/A
- EPS
- POET N/A
- CERS N/A
- Revenue
- POET $119,946.00
- CERS $176,229,000.00
- Revenue This Year
- POET N/A
- CERS $18.57
- Revenue Next Year
- POET $9,744.96
- CERS $10.80
- P/E Ratio
- POET N/A
- CERS N/A
- Revenue Growth
- POET N/A
- CERS 14.71
- 52 Week Low
- POET $1.00
- CERS $1.38
- 52 Week High
- POET $7.79
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- POET 45.38
- CERS 52.01
- Support Level
- POET $4.00
- CERS $1.89
- Resistance Level
- POET $5.21
- CERS $2.24
- Average True Range (ATR)
- POET 0.39
- CERS 0.14
- MACD
- POET -0.08
- CERS -0.00
- Stochastic Oscillator
- POET 42.05
- CERS 24.00
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.